Literature DB >> 21164496

Higher blood pressure associated with higher cognition and functionality among centenarians in Australia.

Robyn Richmond1, Jenaleen Law, Frances Kay-Lambkin.   

Abstract

BACKGROUND: The objective of this study was to examine blood pressure (BP) and cholesterol levels among centenarians in Australia, and to compare the relationship between these biological parameters with cognitive and functional status.
METHODS: We performed BP (n = 142) and cholesterol (n = 67) measurements using the Omron automated sphygmomanometer (Omron Healthcare, Melbourne, Australia) and the LDX Cholestech Analyzer (Inverness Medical, San Diego, CA), respectively. A medical history was also obtained. Cognitive and functional statuses were assessed using the Mini-Mental State Examination (MMSE) and Katz Index of Independence in Activities of Daily Living (Katz ADL), respectively.
RESULTS: Average age of participants was 101.1 years. Hypertension was demonstrated in 1% according to the WHO criterion (≥140/90 mm Hg). However, 38% of centenarians were hypertensive, defined as having a medical diagnosis of hypertension, and/or being on antihypertensive medications, and/or having a BP measurement ≥ 140/90 mm Hg. Mean values were: systolic = 130 mm Hg (90-182 mm Hg), diastolic = 70 mm Hg (44-98 mm Hg), and pulse pressure (PP) = 60 mm Hg (20-130 mm Hg). Hypercholesterolaemia was only detected in 8% of participants. Hypertension was not associated with increased risk of hypercholesterolaemia. Low systolic BP (SBP) and narrower PP was associated with lower MMSE scores. High SBP and wider PP was associated with better functional status.
CONCLUSIONS: Centenarians have a very low prevalence of high BP and high cholesterol compared with the general population. There seems to be an inverse relationship between the risk factors for cardiovascular disease vs. the risk factors for dementia in our sample. There appears to be a complex interaction between BP and health in old age.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164496     DOI: 10.1038/ajh.2010.236

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  17 in total

1.  Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study.

Authors:  María M Corrada; Kathleen M Hayden; Annlia Paganini-Hill; Szofia S Bullain; Jaime DeMoss; Colette Aguirre; Ron Brookmeyer; Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2017-01-17       Impact factor: 21.566

Review 2.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

Review 3.  Hypertension and cognitive function: a review of life-course factors and disparities.

Authors:  Ileana De Anda-Duran; Sara G Woltz; Caryn N Bell; Lydia A Bazzano
Journal:  Curr Opin Cardiol       Date:  2022-07-01       Impact factor: 2.108

4.  Impact of vitamin D receptor polymorphisms in centenarians.

Authors:  Cristina Gussago; Beatrice Arosio; Franca Rosa Guerini; Evelyn Ferri; Andrea Saul Costa; Martina Casati; Elisa Mariadele Bollini; Francesco Ronchetti; Elena Colombo; Giuseppina Bernardelli; Mario Clerici; Daniela Mari
Journal:  Endocrine       Date:  2016-03-08       Impact factor: 3.633

5.  Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study.

Authors:  Arvind Nishtala; Jayandra J Himali; Alexa Beiser; Joanne M Murabito; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Hypertension and cognition decline: Is there an ultimate link?

Authors:  Nereida K C Lima
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-26       Impact factor: 3.738

Review 7.  Macrophages come to mind as keys to cognitive decline.

Authors:  D G Harrison; Tomasz J Guzik
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

8.  To the heart of the problem. mIGF-1: local effort for global impact.

Authors:  Antonio Musarò
Journal:  Aging (Albany NY)       Date:  2012-06       Impact factor: 5.682

9.  Cardioprotective mIGF-1/SIRT1 signaling induces hypertension, leukocytosis and fear response in mice.

Authors:  Giulia Bolasco; Raffaele Calogero; Matteo Carrara; Mumna Al Banchaabouchi; Daniel Bilbao; Gianluigi Mazzoccoli; Manlio Vinciguerra
Journal:  Aging (Albany NY)       Date:  2012-06       Impact factor: 5.682

Review 10.  Hypertension, brain damage and cognitive decline.

Authors:  Dariusz Gąsecki; Mariusz Kwarciany; Walenty Nyka; Krzysztof Narkiewicz
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.